← All bills DISCUSSION →
HOUSE · HR #2343

John W. Walsh Alpha-1 Home Infusion Act of 2025

Set your address to see your representatives
Official Summary
Source: Congress.gov

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Latest ActionsIntroReferral
See all 3 →
Mar 25, 2025 · Latest
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 25, 2025
Introduced in House
Mar 25, 2025
Introduced in House
Read full text
NO VOTES YET
Top discussions 0 comments
No discussions yet. Be the first →
CITIZEN OPINION
NO VOTES YET